Supplemental material, sj-docx-1-opp-10.1177_10781552231164301 for Multiple cardiotoxicities during osimertinib therapy by Hasan Kobat, Michael Davidson, Islam Elkonaissi, Emma Foreman and Shereen Nabhani-Gebara in Journal of Oncology Pharmacy Practice</p